We use cookies for a better user experience. Click here to know more about it. 


Global Inhaled Nitric Oxide Market is Projected to Reach US$ 1,266 Mn by 2023

Author: QYResearch  |   Published Date: 2018-08-17   |   Views: 206


The leading companies own the advantages on better performance, more abundant product’s types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow upward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.

The industry is expected to remain innovation-led, with frequent acquisitions and strategic alliances adopted as the key strategies by the players to increase their industry presence. Market stays in mature period with a clear concentration. Meanwhile, optimize product mix and further develop value-added capabilities to maximize margins.

Market Segment by Manufacturers, this report covers

·        Mallinckrodt

·        Praxair

·        Air Liquide

Market Segment by Type, covers

·        99.92% Purity

·        99.99% Purity

·        Other

Market Segment by Applications, can be divided into

·        ARDS

·        PPHN

·        Other Diseases

Global Inhaled Nitric Oxide Market: Market Driver and Restraint

The Global Inhaled Nitric Oxide market size was 783.77 million USD in 2017 and it will be 1265.95 million USD in 2023, with a CAGR of 8.32% from 2017 to 2023. The Inhaled Nitric Oxide market is growing rapidly in accordance with the growth in the medical gas market. Inhaled NO therapy is commonly used in intensive care units to treat patients with adult respiratory distress syndrome (ARDS), and it appears that inhaled NO is effective in treating conditions that result in pulmonary hypertension, such as, persistent pulmonary hypertension of the neonate (PPHN), and in diseases characterized by disturbances in gas exchange, such as chronic obstructive pulmonary disease (COPD).

Global Inhaled Nitric Oxide Market: Key Takeaways

Though the gross margin is high, but with complex production process and acquisition between enterprises, we tend to believe that this market is going to keep the monopoly status in the forecast period.

Global Inhaled Nitric Oxide Market: Forecast by Region

According to the research, North America and Europe comprised the biggest consumption areas. Other markets like Japan and China are growing relatively slow.

Global Inhaled Nitric Oxide Market: Key Players

The market is highly concentrated, with high technical and professional level. Key vendors in this market are Mallinckrodt, Praxair and Air Liquide, they are taking up to 91.19% market share in 2017. Inhaled Nitric Oxide types commonly used in this market are 800 ppm and 100 ppm, small players tend to produce lower purity products, such as 1000 ppm or so.

Click to view the full report TOC, figure and tables


QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
  • compass minerals
More Clients...